Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
point decrease » point increase (Expand Search)
part decrease » bfrt decreased (Expand Search), a decrease (Expand Search), pa decreased (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
point decrease » point increase (Expand Search)
part decrease » bfrt decreased (Expand Search), a decrease (Expand Search), pa decreased (Expand Search)
-
2641
Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models.
Published 2025Subjects: -
2642
-
2643
The characteristics of patient groups were used to prove the method’s applicability.
Published 2025Subjects: -
2644
-
2645
-
2646
-
2647
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
2648
-
2649
-
2650
-
2651
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
2652
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
2653
-
2654
-
2655
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: -
2656
-
2657
-
2658
-
2659
-
2660